Subclinical reactivation of varicella zoster virus in all stages of HIV infection

被引:26
作者
Birlea, Marius [1 ]
Arendt, Gabriele [2 ]
Orhan, Eser [2 ]
Schmid, D. Scott [3 ]
Bellini, William J. [3 ]
Schmidt, Christian [2 ]
Gilden, Don [1 ,4 ]
Cohrs, Randall J. [1 ]
机构
[1] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA
[2] Univ Dusseldorf, Dept Neurol, Fac Med, D-4000 Dusseldorf, Germany
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
[4] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
VZV; HIV; Subclinical reactivation; CSF; Intrathecal synthesis; VZV IGG ANTIBODY; HERPES-ZOSTER; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; SINE HERPETE; CSF; COMPLICATIONS; BRAIN;
D O I
10.1016/j.jns.2011.02.030
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Analysis of 200 paired serum and cerebrospinal fluid (CSF) samples from 180 HIV-positive individuals, 136 of whom had AIDS, revealed intrathecal synthesis of antibodies specific for varicella zoster virus (VZV) in 28 (16%) individuals, measles virus in 15 (8%), herpes simplex virus-1 (HSV-1) in 1 (0.6%), and HSV-2 in none. Of the 28 subjects with a positive VZV antibody specificity index, only 1 had zoster rash at the time of serum and CSF sampling; of the total 180 HIV-positive subjects, 146(81%) had no history of zoster. Based on an estimated 33.4 million HIV-positive individuals worldwide, subclinical reactivation of VZV in even less than 16% of HIV-positive people suggests the possibility that millions of people have active VZV infection of the central nervous system. In cases of VZV vasculopathy, myelopathy and even zoster sine herpete, the CSF is often positive for anti-VZV antibody, but negative for VZV DNA. To rule out VZV infection of the nervous system, CSF must be tested for VZV DNA and anti-VZV IgG and IgM antibody. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:22 / 24
页数:3
相关论文
共 24 条
[1]   ZOSTER SINE HERPETE: VIROLOGIC VERIFICATION BY DETECTION OF ANTI-VZV IgG ANTIBODY IN CSF [J].
Blumenthal, D. T. ;
Shacham-Shmueli, E. ;
Bokstein, F. ;
Schmid, D. S. ;
Cohrs, R. J. ;
Nagel, M. A. ;
Mahalingam, R. ;
Gilden, D. .
NEUROLOGY, 2011, 76 (05) :484-485
[2]   VIROLOGICAL MARKERS IN THE CEREBROSPINAL-FLUID FROM HIV-1-INFECTED INDIVIDUALS [J].
BUFFET, R ;
AGUT, H ;
CHIEZE, F ;
KATLAMA, C ;
BOLGERT, F ;
DEVILLECHABROLLE, A ;
DIQUET, B ;
SCHULLER, E ;
PIERROTDESEILLIGNY, C ;
GENTILINI, M ;
HURAUX, JM .
AIDS, 1991, 5 (12) :1419-1424
[3]   Varicella Zoster Virus Is Not a Disease-Relevant Antigen in Multiple Sclerosis [J].
Burgoon, Mark P. ;
Cohrs, Randall J. ;
Bennett, Jeffrey L. ;
Anderson, Sarah W. ;
Ritchie, Alanna M. ;
Cepok, Sabine ;
Hemmer, Bernhard ;
Gilden, Don ;
Owens, Gregory P. .
ANNALS OF NEUROLOGY, 2009, 65 (04) :474-479
[4]   Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients [J].
Burke, DG ;
Kalayjian, RC ;
Vann, VR ;
Madreperla, SA ;
Shick, HE ;
Leonard, DGB .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04) :1080-1084
[5]  
Castro KG, 1992, MMWR-MORBID MORTAL W, V41, P1, DOI DOI 10.2307/42000431
[6]   Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts [J].
Cohrs, Randall J. ;
Mehta, Satish K. ;
Schmid, D. Scott ;
Gilden, Donald H. ;
Pierson, Duane L. .
JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (06) :1116-1122
[7]  
de la Blanchardiere A, 2000, SCAND J INFECT DIS, V32, P263, DOI 10.1080/00365540050165893
[8]   Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection [J].
Gershon, AA ;
Mervish, N ;
LaRussa, P ;
Steinberg, S ;
Lo, SH ;
Hodes, D ;
Fikrig, S ;
Bonagura, V ;
Bakshi, S .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (06) :1496-1500
[9]   ZOSTER SINE HERPETE, A CLINICAL VARIANT [J].
GILDEN, DH ;
WRIGHT, RR ;
SCHNECK, SA ;
GWALTNEY, JM ;
MAHALINGAM, R .
ANNALS OF NEUROLOGY, 1994, 35 (05) :530-533
[10]   Neurological Disease Produced by Varicella Zoster Virus Reactivation Without Rash [J].
Gilden, Don ;
Cohrs, Randall J. ;
Mahalingam, Ravi ;
Nagel, Maria A. .
VARICELLA-ZOSTER VIRUS, 2010, 342 :243-253